Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today […]
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]
PDC*line Pharma Opens Last Cohort of PDC-LUNG-101 Clinical Trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable […]
WELL Health Adds Chief Medical Officer Sean Kelly to Leadership Team
Well Health Inc., a SaaS digital health leader in patient communications and 2021 Best in KLAS […]
Biomunex Pharmaceuticals’ Breakthrough Immunotherapy Project Receives Grants Close to €3 Million
Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapy through the discovery and development of bi- and multi-specific […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
Closed Loop Medicine Closes £13 Million Financing
Closed Loop Medicine (the “Company”), the global leader in the development of single prescription drug […]
SAGA Diagnostics Enters into Development Agreement with AstraZeneca
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology […]
BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of […]
Draper Esprit Leads $17.5 Million Series A in Hypertension Health-tech Firm Aktiia
Draper Esprit, a leading venture capital firm investing in and developing high growth technology businesses, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more